Bausch Health Announces 2024 Gastrointestinal Health Scholars Program Winners

August 13, 2024 7:00 AM

For Fifth Consecutive Year, 10 Students with Gastrointestinal Disease Will Each Receive a $10,000 ScholarshipLAVAL, QC / ACCESSWIRE / August 13, 2024 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) and its gastroenterology (GI) business, Salix Pharmaceuticals ("Salix"), today announced the recipients of its 2024 Salix Gastrointestinal Health Scholars Program. For the fifth year, Bausch Health is proud to award 10 deserving students living...

Read more

Cantargia Presents the Interim Report for Q2 2024 on August 28 at 3.00 p.m.

August 13, 2024 4:15 AM

LUND, SE / ACCESSWIRE / August 13, 2024 / Cantargia (STO:CANTA) Cantargia (Cantargia AB; Nasdaq Stockholm:CANTA) will publish the company's interim report for January to June 2024 on Wednesday, August 28, 2024, at 07:00 a.m. CEST. In conjunction to the report, Cantargia invites investors, analysts, and media to an audiocast with teleconference (in English) on August 28, at 3:00 p.m. CEST, where Cantargia's CEO, Göran Forsberg, and CFO, Patrik...

Read more

New Scientific Article on NeuroRestore ACD856 and its Improved Cognition and Disease Modification of Alzheimer’s Disease

August 13, 2024 2:20 AM

STOCKHOLM, SE / ACCESSWIRE / August 13, 2024 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB (publ) (FN STO:ALZCUR), a pharmaceutical company that develops candidate drugs for diseases affecting the nervous system, focusing on Alzheimer's disease and pain, today announced that a scientific article has been published on the underlying biological mechanisms behind the NeuroRestore platform and the interesting opportunities this entails...

Read more

Evotec Announces Strong Progress in Strategic Protein Degradation Partnership with Bristol Myers Squibb

August 13, 2024 2:00 AM

Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) today announced further strong progress of the Company's strategic partnership with Bristol Myers Squibb relating to building a molecular glue-based pipeline. Performance-based and programme-based achievements trigger payments of in total US$ 75 m to Evotec.Initiated in 2018, the partnership combines Evotec's high-performance multi-omics screening and...

Read more

Dr. Greg Hanley Joins Action Behavior Centers

August 12, 2024 1:10 PM

Action Behavior Centers is thrilled to announce the appointment of Dr. Greg Hanley, BCBA-D as the Executive Director of Compassionate Care, who will be heading a new organization-wide initiative to train, mentor and support clinicians in the provision of compassionate and effective treatment for challenging behavior. Dr. Hanley brings over 25 years of experience in leadership roles, serving in both academic and clinical settings and has more...

Read more

REMINDER: Jaguar Health to Hold Investor Webcast Tuesday, August 13th at 8:30 AM Eastern to Review Q2 Earnings and Further Review Phase 3 OnTarget Trial’s Clinically Meaningful Results in Breast and Lung Cancer Patients

August 12, 2024 10:00 AM

SAN FRANCISCO, CA / ACCESSWIRE / August 12, 2024 / Jaguar Health, Inc. (NASDAQ:JAGX) today issued a reminder that the company will conduct an investor webcast on Tuesday, August 13, 2024 at 8:30 a.m. Eastern to review second-quarter 2024 financials and provide corporate updates.Participation Instructions for WebcastWhen: Tuesday, August 13, 2024 at 8:30 AM Eastern TimeParticipant Registration & Access Link: Click HereReplay Instructions for...

Read more

BioTech Medics-OTC CEO Interview and the Company Launches Its YouTube Channel

August 12, 2024 9:00 AM

WOODLAND HILLS, CA / ACCESSWIRE / August 12, 2024 / BioTech Medics, Inc. (OTC PINK:BMCS) is pleased to announce that the company's CEO sat down for an interview with The Beast of Wall Street on August 8, 2024 to discuss the past present and future of BioTech Medics, Inc. This interview can be found at the following link: https://x.com/dsalzarulo/status/1821592473652883916?s=46 additionally an excerpt of this interview can be found on the...

Read more

Monogram Technologies Secures Initial Strategic Clinical Trial Collaboration

August 12, 2024 8:30 AM

Monogram Technologies Inc. (NASDAQ:MGRM) ("Monogram" or the "Company"), an AI-driven robotics company focused on improving human health with an initial focus on orthopedic surgery, today announced its strategic collaboration with Shalby Limited (NSE:SHALBY) ("Shalby"), a global muti-specialty hospital chain and one of India's leading orthopedic hospital groups, to conduct a multicenter clinical trial to demonstrate the safety and effectiveness...

Read more

R1 RCM Named Top Performing Revenue Cycle Management Outsourcing Provider by 2024 Black Book Health Systems Client Survey

August 12, 2024 8:00 AM

Managed services customers validated highest client satisfaction ratings on R1 RCM, a major player in the medical financial services industry that is working with 95 of the top 100 U.S. health systems and managing over $55 billion in net patient revenue.TAMPA, FL / ACCESSWIRE / August 12, 2024 / R1 RCM has been recognized as the premier vendor for outsourced Revenue Cycle Management (RCM) services tailored to health systems, networks, and...

Read more

MIRA Pharmaceuticals Unveils Ketamir-2's Principal Metabolite: Nor-Ketamir - a Longer-Acting, Brain Penetrating and Selective Compound Acting on the NMDA PCP Receptor

August 12, 2024 8:00 AM

This breakthrough in bioavailability and formulation showcases the potential for advanced, at home neurological treatments.MIAMI, FL / ACCESSWIRE / August 12, 2024 / MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA), or MIRA Pharmaceuticals, a leading pre-clinical-stage pharmaceutical company unveiled new preclinical data providing further insights into the mechanism of action of its innovative drug candidate, Ketamir-2's principal metabolite,...

Read more

CBD Life Sciences, Inc. (CBDL) Welcomes Major Political Endorsement for Cannabis Legalization

August 12, 2024 8:00 AM

CBD Life Sciences Inc. (OTC PINK:CBDL), including its wholly owned subsidiary, The CBD Vault Inc., a rapidly expanding CBD company headquartered in Scottsdale, Arizona, proudly supports the recent endorsement of cannabis legalization by the Harris-Walz presidential ticket. This historic move marks the first time a major U.S. presidential ticket has openly advocated for the federal legalization of cannabis, a development that could significantly...

Read more

Ainos to Participate in Fireside Chat with Water Tower Research on August 22, 2024

August 12, 2024 8:00 AM

Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos", or the "Company"), a diversified healthcare company focused on novel AI-powered point-of-care testing ("POCT") and VELDONA low-dose interferon therapeutics, today announced that it will participate in a fireside chat with Do Kim, senior research analyst of Water Tower Research ("WTR") on Thursday, August 22, 2024 at 10:00 a.m. ET.Mr. Jack Lu, Ainos' Director of Corporate Development, will provide...

Read more

Theralase(R) Release’s 2Q2024 Financial Statements

August 12, 2024 7:00 AM

Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company dedicated to the research and development of light and/or radiation activated small molecules for the safe and effective destruction of various cancers, bacteria and viruses has released the Company's unaudited condensed consolidated interim financial statements for the six-month period ended June 30, 2024. ("Financial...

Read more

Interactive Strength Inc. (Nasdaq: TRNR) Wins Appeal for Continued Nasdaq Listing

August 12, 2024 7:00 AM

Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or "the Company"), maker of innovative specialty fitness equipment under the CLMBR and FORME brands, today announced that the Company received a letter stating that the Nasdaq Hearings Panel has granted the Company's request for continued listing on the Nasdaq Stock Market.As of March 31, 2024, the Company was not in compliance with Listing Rule 5550(b)(1) (the "Equity Rule") which specifies a...

Read more

Diabetics Trust Launches New Platform to Support Students with Diabetes

August 12, 2024 4:15 AM

Diabetics Trust has introduced an innovative solution aimed at empowering students who manage diabetes, helping them improve their financial stability while navigating the demands of student life. By offering a dedicated platform where individuals can receive cash for diabetic test strips and other unused supplies, Diabetics Trust addresses a growing need within the student community. Many students, already facing the dual challenge of managing...

Read more

Ainos Secures Exclusive Multi-Regions Invention Patent Licenses from Strategic Partner to Bolster AI Nose and Point-Of-Care Testing

August 9, 2024 4:15 PM

SAN DIEGO, CA / ACCESSWIRE / August 9, 2024 / Ainos, Inc. (NASDAQ:AIMD, AIMDW) ("Ainos", or the "Company"), a diversified healthcare company focused on novel AI-powered point-of-care testing ("POCT") and VELDONA low-dose interferon therapeutics, today announced that it has obtained exclusive licenses for a total of 10 invention patents and patent applications from Taiwan Carbon Nano Technology ("TCNT"), the Company's affiliate and product...

Read more

Xtant Medical Announces Closing of $5.0 Million Private Placement

August 9, 2024 4:05 PM

Xtant Medical Holdings, Inc. (NYSE American:XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the closing of its previously announced $5.0 million private placement with an existing institutional investor. The Company sold 7,812,500 shares of common stock at a purchase price of $0.64 per share. After deducting fees and other estimated offering expenses, the Company...

Read more

Biofrontera Inc. to Report Second Quarter Financial Results on August 14, 2024

August 9, 2024 10:00 AM

WOBURN, MA / ACCESSWIRE / August 9, 2024 / Biofrontera Inc. (Nasdaq:BFRI), a biopharmaceutical company specializing in the commercialization of dermatological products, announces it will report financial results for the three and six months ended June 30, 2024 on Wednesday, August 14, 2024. The results will be released after the market close on Wednesday, Aug 14 and the company will host a conference call on Thursday, August 15 at 10:00am...

Read more

MedEvolve Rated Top Revenue Cycle Management Workflow Optimization and Automation Solution, 2024 Black Book RCM Client Survey

August 9, 2024 8:00 AM

TAMPA, FL / ACCESSWIRE / August 9, 2024 / Black Book Research announces that MedEvolve has been named the top vendor for Revenue Cycle Management (RCM) workflow optimization and automation services, as recognized by clients in the Q3 2024 satisfaction survey. The survey included feedback from 1,887 providers, medical group financial system users, and business office leaders. Among over 200 core and niche RCM technology vendors, MedEvolve...

Read more

FSD Pharma Provides Update on its Investment in Celly Nutrition Corp. Who Secures Additional Financing to Launch unbuzzd(TM) Stick Packs this Month - Created by a World-Class Pharmaceutical Research & Development Team

August 9, 2024 7:30 AM

TORONTO, ON / ACCESSWIRE / August 9, 2024 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma"), provides an update on its investment in Celly Nutrition Corp. ("Celly Nu"), a privately held Canadian company launching an innovative beverage product that can assist in Expediting Alcohol Metabolism and Faster Recovery from Alcohol Consumption.On August 9, 2024, Celly Nutrition which is backed by a world-class pharmaceutical research &...

Read more